TIDMGSK

RNS Number : 7922Z

GlaxoSmithKline PLC

14 January 2020

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             1370.518 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Connor 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Vaccines 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             551.656 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms D Conrad 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Human Resources 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             6.696 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr J Ford 
====  ========================================  ==================================================== 
 b)    Position/status                          SVP & General Counsel 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 9 
                                                 January 2020. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $47.0819                0.00127 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-01-10 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr J Ford 
====  ======================================  ================================================= 
 b)    Position/status                        SVP & General Counsel 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             0.000024 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr N Hirons 
====  ========================================  ==================================================== 
 b)    Position/status                          SVP, Global Ethics & Compliance 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 9 
                                                 January 2020. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $47.0819                17.000 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-01-10 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr N Hirons 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Ethics & Compliance 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             319.264 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms S Jackson 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Communications and CEO Office 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             39.806 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                   Mr D Jackson 
====  ======================================  ===================================================== 
 b)    Position/status                        PCA of Ms S Jackson (SVP, Global Communications 
                                               and CEO Office) 
====  ======================================  ===================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ===================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ===================================================== 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ===================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ===================== 
   GBP18.0083                                                               42.882 
   =======================================================================  ===================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ====================================================================  ============================ 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ===================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr B McNamara 
====  ========================================  ==================================================== 
 b)    Position/status                          CEO, GSK Consumer Healthcare 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 9 
                                                 January 2020. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $47.0819                681.093 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2020-01-10 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr D Redfern 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Strategy Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             2268.962 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Simard 
====  ======================================  ================================================= 
 b)    Position/status                        President, Pharmaceuticals Supply Chain 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             436.188 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr P Thomson 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             521.767 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms K Thomson 
====  ======================================  ================================================= 
 b)    Position/status                        PCA of Mr P Thomson (President, Global 
                                               Affairs) 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             113.744 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms D Waterhouse 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer of ViiV Healthcare 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 9 January 2020. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP18.0083                                                             65.603 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2020-01-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHEZLFFBFLEBBK

(END) Dow Jones Newswires

January 14, 2020 11:01 ET (16:01 GMT)

Gsk (LSE:GSK)
過去 株価チャート
から 2 2024 まで 3 2024 Gskのチャートをもっと見るにはこちらをクリック
Gsk (LSE:GSK)
過去 株価チャート
から 3 2023 まで 3 2024 Gskのチャートをもっと見るにはこちらをクリック